| [1] |
Li Jinhao, Hu Dongmei, Xu Caihong.
Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407.
|
| [2] |
Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu.
Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
|
| [3] |
Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong.
Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
|
| [4] |
An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui.
Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
|
| [5] |
Song Feier, Mao Yanjun, Xia Qiuyue, Zhou Yang, Lin Huan.
The prevalence and influencing factors of post-tuberculosis lung disease: A Meta-analysis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 322-330.
|
| [6] |
Qin Xueling, Chen Li, Sun Xiaoying, Hu Shanpeng, Lu Zhen, He Nailing, Zhang Jifen.
Active screening and influencing factor analysis of pulmonary tuberculosis among elderly people
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 355-361.
|
| [7] |
Xue Yu, Yang Xinting, Wang Guirong, Liu Fangchao, Lei Xuan, Zhang Jing, Li Liang.
Analysis of risk factors for death in emergency pulmonary tuberculosis patients and risk model construction
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 189-194.
|
| [8] |
Wang Dafu, Ma Xiaoxue, Wang Yun, Li Fudong, Rao Wen, Gong Tingting, Li Shijun, Li Jinlan.
Analysis of risk factors for patient delay and adverse treatment outcomes among patients with pulmonary tuberculosis and diabetes mellitus in Guizhou Province, 2016—2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 201-209.
|
| [9] |
Li Xueqiu, Liu Qun, Tang Ke, Wu Di.
Analysis of mortality trend of pulmonary tuberculosis cases with an age-period-cohort model in Guangzhou City, 2011—2020
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 44-50.
|
| [10] |
Shi Yilin, Gu Yan.
Meta-analysis of the efficacy, adverse reactions, and fatality rate of glucocorticoid combined with anti-tuberculosis drugs in the treatment of tuberculous serositis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 77-86.
|
| [11] |
Sun Danyuchen, Liu Yuhong.
Research progress on active case finding of tuberculosis in the elderly population: a literature review
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 96-101.
|
| [12] |
Tang Mi, Li Yao, Hu Yanmei, Wen Xinmin, Tang Zhigang, Huang Sheng, Zhang Yong, Luo Danlin, Yi Hengzhong.
Single-cell sequencing reveals differences in natural killer cells between young and elderly patients with severe pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1030-1036.
|
| [13] |
Huang Tao, Jian Huiyong, Wang Xinqi, Liu Nianqiang, Yipar Aihaiti, Wang Mingzhe, Jiayinati Jingesi, Wang Senlu.
Analysis of influencing factors of treatment outcomes in patients with pulmonary tuberculosis complicated with diabetes mellitus in Xinjiang Uygur Autonomous Region
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1083-1088.
|
| [14] |
Cai Qinghe, Fu Hui, Chen Ruiming, Fan Youming, Yang Qingwei.
Analysis of the clinical characteristics and influencing factors of pulmonary tuberculosis patients with diabetes mellitus in Shantou City from 2016 to 2022
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 926-934.
|
| [15] |
Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei.
Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
